TrialClinical lymphoma, myeloma & leukemia2018

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.

Victor Yazbeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.